The DOI matches its Crossref record; 29 of the 31 references it cites were found in a registry or an index.
Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2): A Randomized Trial
Open accessAbstract
IMPORTANCE: Atrial fibrillation (AF) is the most common rhythm disorder seen in clinical practice. Antiarrhythmic drugs are effective for reduction of recurrence in patients with symptomatic paroxysmal AF. Radiofrequency ablation is an accepted therapy in patients for whom antiarrhythmic drugs have failed; however, its role as a first-line therapy needs further investigation. OBJECTIVE: To compare radiofrequency ablation with antiarrhythmic drugs (standard therapy) in treating patients with paroxysmal AF as a first-line therapy. DESIGN, SETTING, AND PATIENTS: A randomized clinical trial involving 127 treatment-naive patients with paroxysmal AF were randomized at 16 centers in Europe and North America to received either antiarrhythmic therapy or ablation. The first patient was enrolled July 27, 2006; the last patient, January 29, 2010. The last follow-up was February 16, 2012. INTERVENTIONS: Sixty-one patients in the antiarrhythmic drug group and 66 in the radiofrequency ablation group were followed up for 24 months. MAIN OUTCOMES AND MEASURES: The time to the first documented atrial tachyarrhythmia of more than 30 seconds (symptomatic or asymptomatic AF, atrial flutter, or atrial tachycardia), detected by either scheduled or unscheduled electrocardiogram, Holter, transtelephonic monitor, or rhythm strip, was the primary outcome. Secondary outcomes included symptomatic recurrences of atrial tachyarrhythmias and quality of life measures assessed by the EQ-5D tool. RESULTS: Forty-four patients (72.1%) in the antiarrhythmic group and in 36 patients (54.5%) in the ablation group experienced the primary efficacy outcome (hazard ratio [HR], 0.56 [95% CI, 0.35-0.90]; P = .02). For the secondary outcomes, 59% in the drug group and 47% in the ablation group experienced the first recurrence of symptomatic AF, atrial flutter, atrial tachycardia (HR, 0.56 [95% CI, 0.33-0.95]; P = .03). No deaths or strokes were reported in either group; 4 cases of cardiac tamponade were reported in the ablation group. In the standard treatment group, 26 patients (43%) underwent ablation after 1-year. Quality of life was moderately impaired at baseline in both groups and improved at the 1 year follow-up. However, improvement was not significantly different among groups. CONCLUSIONS AND RELEVANCE: Among patients with paroxysmal AF without previous antiarrhythmic drug treatment, radiofrequency ablation compared with antiarrhythmic drugs resulted in a lower rate of recurrent atrial tachyarrhythmias at 2 years. However, recurrence was frequent in both groups. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00392054.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As first-line treatment for paroxysmal AF, randomized trials showed only modestly improved rhythm outcome with catheter ablation compared to antiarrhythmic drug therapy.585,[721][722][723]”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [722]
In the citing paper
“Complication rates were similar, but ablation was performed in expert centres, justifying catheter ablation as first-line therapy in selected patients with paroxysmal AF who ask for interventional therapy.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [722]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Cox’s regression model for counting processes: A large sample study
Andersen, P. K., & Gill, R. D. (1982) · The Annals of Statistics · doi:10.1214/aos/1176345976 · Cited by 4,419
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,823
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs253 · Cited by 2,929
Cappato, R., Calkins, H., Chen, S.-A., Davies, W., Iesaka, Y., Kalman, J., Kim, Y.-H., Klein, G., Natale, A., Packer, D., et al. (2010) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.859116 · Cited by 2,852
Self-citationWang, T. J., Larson, M. G., Levy, D., Vasan, R. S., Leip, E. P., Wolf, P. A., D’Agostino, R. B., Murabito, J. M., Kannel, W. B., & Benjamin, E. J. (2003) · Circulation · doi:10.1161/01.cir.0000072767.89944.6e · Cited by 1,970
Calkins, H. G., Brugada, J., Packer, D. L., Cappato, R., Chen, S., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Haines, D. E., Haı̈ssaguerre, M., et al. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.04.005 · Cited by 1,690
Self-citationCalkins, H. G., Brugada, J., Packer, D. L., Cappato, R., Chen, S.-A., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Haines, D. E., Haïssaguerre, M., et al. (2007) · EP Europace · doi:10.1093/europace/eum120 · Cited by 1,289
Self-citationWilber, D. J., Pappone, C., Neuzil, P., De Paola, A., Marchlinski, F., Natale, A., Macle, L., Daoud, E. G., Calkins, H., Hall, B., et al. (2010) · JAMA · doi:10.1001/jama.2009.2029 · Cited by 1,170
Self-citation
Flagged first, then by citations
2 of the 31 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- EuroQol Group, 2007, EQ-5D Value Sets: Inventory, Comparative Eview and User Guide
Cited by
Sorted by citations
Items 601–667 of 667
Zhong, L., Yin, X., & Xie, Z. (2020) · Journal of International Medical Research · doi:10.1177/0300060520949760
RetractedAtrial fibrillation ablation after the CABANA study: beyond statistical dogma
Roca‐Luque, I., Tolosana, J. M., & Brugada, J. (2020) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2020.07.014
Role of Catheter Ablation as a First-Line Treatment for Atrial Fibrillation
Masri, I. E., Kayali, S. M., Manolukas, T., & Levine, Y. C. (2020) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-020-00840-y
Nativel, F., Barge, F., Prevost, N., Solnon, A., Gourraud, J., Probst, V., Clouet, J., Lande, G., & Grimandi, G. (2020) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2020.10.004
Riddle, M., McCallum, R. W., Ojha, C. P., Paul, T. K., Gupta, V., Baran, D. A., Prakash, B. V., Misra, A., Mares, A. C., Abedin, M., et al. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001500
Adeola, O., Aboud, A. A., Richardson, T. D., & Michaud, G. F. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14913
AF Radiofrequency Ablation Using CARTO 3D System
Madadi, S. (2021) · Springer eBooks · doi:10.1007/978-1-4471-7496-7_26
Sun, Y., Wang, L., & Yang, X. (2021) · Aging · doi:10.18632/aging.202676
Sano, H., Hirano, T., Koarai, A., & Ichinose, M. (2020) · European Respiratory Society eBooks · doi:10.1183/2312508x.10029119
Katheterablation bei asymptomatischem Vorhofflimmern – Wer profitiert?
Hindricks, G., & Darma, A. (2021) · Aktuelle Kardiologie · doi:10.1055/a-1471-2616
Mugnai, G., de Asmundis, C., Sorgente, A., & Chierchia, G. (2021) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001206
Mikhaylov, E. N., Gasimova, N. Z., Ayvazyan, S. A., Artyukhina, Е. А., Алексеевич, Г. Г., Иваницкий, Э. А., Колунин, Г. В., Морозов, А. Н., Nardaya, S. G., Rybachenko, M. S., et al. (2021) · Journal of Arrhythmology · doi:10.35336/va-2021-e-3-16
Katritsis, D. G., & Morady, F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-79338-4.00022-4
Barrett, C. D., Kim, R., Sink, E. M., Tumolo, A. Z., Zipse, M. M., Aleong, R. G., Garg, L., Sandhu, A., West, J. J., Varosy, P. D., et al. (2022) · doi:10.2196/preprints.38097
Chun, K.-R. J., Bordignon, S., & Schmidt, B. (2019) · CardioVasc · doi:10.1007/s15027-019-1541-1
Mandsager, K. T., & Phelan, D. M. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-69384-8_10
Hashimoto, K., Kobayashi, M., Kakegawa, T., Suzuki, K., Negishi, T., Tsuzuki, I., Seki, Y., Ibe, S., Yamashita, T., Miyama, H., et al. (2022) · Japanese Journal of Electrocardiology · doi:10.5105/jse.42.73
First-Line Approach for Rhythm Control in Paroxysmal Atrial Fibrillation
Bisignani, A., Pannone, L., Sorgente, A., de Asmundis, C., & Chierchia, G. (2022) · JACC Case Reports · doi:10.1016/j.jaccas.2022.07.001
Pitvarfibrilláció-abláció szívelégtelenségben
Tóth, P., Komlósi, F., Vámosi, P., Kazay, Á., Arnóth, B., Salló, Z., Perge, P., Piros, K., & Nagy, K. V. (2022) · Cardiologia Hungarica · doi:10.26430/chungarica.2022.52.3.218
Atrial Fibrillation in Heart Failure: Rate or Rhythm Control Strategy
Lubis, A. C., Munawar, D. A., & Munawar, M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105777
Watanabe, T., Tachibana, K., Shinoda, Y., Minamisaka, T., Fukuoka, H., Inui, H., Ueno, K., Inoue, S., Mine, K., & Hoshida, S. (2022) · Research Square · doi:10.21203/rs.3.rs-2171440/v1
Kaushik, N., Chapman, J. A., Gillaspie, A., Ackerman, S. J., Gallagher, P. L., Mallick, D. C., & Bailin, S. J. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106319
QOL and PROMS in Catheter Ablation of Cardiac Arrhythmia
Withers, K. L., Morgan, H., & Lencioni, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-09815-4_16
Lesion Size Index‐guided high‐power ablation for atrial fibrillation: Opening the therapeutic window
Hanley, A. (2023) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15836
Tsaregorodtsev, D. A., Khalikova, M. A., Vasyukov, S. S., Beraya, M. M., & Sedov, A. V. (2023) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2023-03-09
Kang, D., Kim, D., Jang, E., Yu, H. T., Kim, T., Uhm, J., Sung, J., Pak, H., Lee, M., Yang, P., et al. (2023) · medRxiv · doi:10.1101/2023.07.26.23293221
张, 梓. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1392035
Hashimoto, K., Kakegawa, T., Suzuki, K., Negishi, T., Tsuzuki, I., Seki, Y., Ibe, S., Yamashita, T., Miyama, H., Fujisawa, T., et al. (2023) · Advances in Precision Medicine · doi:10.18063/apm.v7i2.243
Janosi, K.-F., Debreceni, D., Bocz, B., Torma, D., Keseru, M., Símor, T., & Kupó, P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13041029
Pan, Y., Zeng, H., Liu, X., Fu, X., Pan, L., & Wang, Y. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4755300
Les indications de l’ablation de fibrillation atriale
Deharo, J. (2024) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2024.02.014
Cardiac Rhythms and Cardiovascular Outcomes
Kreidieh, B., Keramati, A. R., & Kowey, P. R. (2024) · Contemporary cardiology · doi:10.1007/978-3-031-54960-1_15
Kaye, A. D., Jones, N. T., Tran, T., Khaled, M. E., Tilmon, S., Lieu, M., Drinkard, J., Torres, Y. L., Herron, E. W., Ahmadzadeh, S., et al. (2024) · Cureus · doi:10.7759/cureus.62728
New Therapeutic Strategies in Managing Atrial Fibrillation in Heart Failure
Akinrimisi, O. P., & Perez, M. V. (2024) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-024-01051-5
Clinical Trials for Atrial Fibrillation—What Do We Know?
Kerr, N. P., Chew, D. S., & Wilton, S. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00023-6
Pulmonary Vein Isolation Using Radiofrequency Energy Ablation Technologies
Gianni, C., Santangeli, P., Al‐Ahmad, A., Burkhardt, J. D., Horton, R. P., Sánchez, J., & Natale, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93110-6.00015-3
Self-citationAblation of Persistent and Long-Standing Persistent Atrial Fibrillation
Montgomery, J. A., Kowal, J. L., & Michaud, G. F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93110-6.00020-7
Obeidat, O., Ismail, M. F., Abughazaleh, S., Al‐Ani, H., Tarawneh, M., Alhuneafat, L., Obeidat, A. M., Alqudah, Q., Daise, M. A., Alzghoul, H., et al. (2024) · Medicine International · doi:10.3892/mi.2024.200
Kim, S., Kim, K. A., Park, S.-Y., Kim, H., Choi, Y., Oh, Y., & Kim, S. (2024) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.15105
Hilu, R., Suleiman, M. A., Elias, A., Marai, I., Beinart, R., Nof, E., Michowitz, Y., Glikson, M., Konstantino, Y., Haim, M., et al. (2025) · CJC Open · doi:10.1016/j.cjco.2025.01.014
Pan, Y., Zeng, H., Liu, X., Fu, X., Pan, L., & Wang, Y. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1461744
Ikeda, H., Hasegawa, K., Uzui, H., Mukai, M., Tama, N., Ishida, K., & Tada, H. (2025) · International Heart Journal · doi:10.1536/ihj.24-676
Editorial commentary: Underdosed and overlooked: Antiarrhythmic drug therapy for atrial fibrillation
Mitrani, R. D., Velasquez, A. H., & Goldberger, J. J. (2025) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2025.08.011
Mannewald, C., Platonov, P. G., Fengsrud, E., Höglund, N., Karlsson, L., Lönnerholm, S., Schwieler, J. H., Ringborn, M., Landén, R., Tabrizi, F., et al. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf142
Katheterablation von paroxysmalem Vorhofflimmern – aktuelle Aspekte
Schäffer, B., Hoffmann, B. A., Sultan, A., Schreiber, D., Akbulak, Ö., Moser, J., Steven, D., & Willems, S. (2014) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-014-0332-8
Chander, S., Kumari, R., Luhana, S., Shiwlani, S., Parkash, O., Sorath, F., Wang, H. Y., Tan, S., Rahaman, Z., Mohammed, Y. N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26738823
Barboza, J. J., Paz, F. D., Saldaña, C. D., Ayca, M. S., Alarcón, M. J., Medrano, J. M., Luque, A. H., Bonilla-Asalde, C., & Rivera-Lozada, O. (2025) · Research Square · doi:10.21203/rs.3.rs-7820043/v1
Ablation for Atrial Fibrillation: Can We Individualise Therapy or Should One Size Fit All?
Spath, N. B., Martin, R. I. R., Das, M., Gonna, H., Sanders, P., & Kadhim, K. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm43927
THE CHOICE OF GENERAL ANESTHETIC FOR ELECTROPHYSIOLOGICAL INTERVENTIONS ON HEART
Андреевич, В. А. (2025) · Minimally Invasive Cardiovascular Surgery · doi:10.64218/3033-5426-2025-1-3-43-51
Natale, A., Mohanty, S., Andrade, J. G., & MANSOUR, M. C. (2026) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2025.12.024
Self-citationПотешкина, Н. Г., Shashkina, Y. R., Анатольевна, К. Е., Gorev, M. V., Karasev, A. A., & Владимировна, С. И. (2026) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2026-16-1-28-37
Rier, S. C., Semino, T., Zan, G. D., Guglielmo, M., Ramanna, H., van der Heijden, J. F., Hendriks, A. A., Cramer, M. J., van der Harst, P., van Driel, V. J. H. M., et al. (2026) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-026-03655-3
Wiedmann, F., Prodanova, A., Kraft, M. K., Weitkamp, F. M., Paasche, A., Goetz, C., & Schmidt, C. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1780526
Zhang, W., Wang, J., Zhu, M., Chen, H., WU, Z., & Hao, J. (2026) · Research Square · doi:10.21203/rs.3.rs-8687602/v1
Xin, Y., Li, J., song, H., Cui, L., Yu, H., Chu, Y., & Dong, S. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05860-3
Garg, K. A., Saini, P. K., Chauhan, R., Kailey, K. R., Sood, K. S., Pannu, A., Kaur, N., & Vala, L. (2026) · Advanced Biomedical Research · doi:10.4103/abr.abr_272_24
PVI Durability After PFA or RFA in Persistent-AF
Galuszka, O., Kueffer, T., Baldinger, S. H., Servatius, H., Herrera‐Siklody, C., Kozhuharov, N., Thalmann, G., Madaffari, A., Haeberlin, A., Noti, F., et al. (2026) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2026.04.027
Narita, M., Kawano, D., Tanaka, N., Naganuma, T., Sasaki, W., Matsumoto, K., Matsumoto, K., Mori, H., Ikeda, Y., & Kato, R. (2026) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.70376
Impact of Carina Width on Re‐Ablation Rate of Atrial Fibrillation After Primary Cryoballoon‐Ablation
Müller, M., Hedman, M., Heikkilä, M., & Junttila, J. M. (2026) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.70430
2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation
Benjamin, E. J., Marcus, G. M., Hess, P. L., Addison, D., Akar, J. G., Brownell, N. K., Chyou, J. Y., Derington, C. G., Diekemper, R. L., Frankel, D. S., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.05.032
Benjamin, E. J., Marcus, G. M., Hess, P. L., Addison, D., Akar, J. G., Brownell, N. K., Chyou, J. Y., Derington, C. G., Diekemper, R. L., Frankel, D. S., et al. (2026) · Circulation Population Health and Outcomes · doi:10.1161/hcq.0000000000000149
Liu, X., Singer, D. E., Heist, E. K., & Lin, K. J. (2026) · European Heart Journal Open · doi:10.1093/ehjopen/oeag128
Molatta, S., Niemeier, A., Hamriti, M. E., Braun, M., Noelker, G., Schubert, S., & Sommer, P. (2026) · Journal of Cardiology and Cardiovascular Medicine · doi:10.29328/journal.jccm.1001227
Rier, S. C., Semino, T., Guglielmo, M., Ramanna, H., van der Heijden, J. F., Hendriks, A. A., Cramer, M. J., van der Harst, P., van Driel, V. J. H. M., & van der Bilt, I. (2026) · Heart Rhythm O2 · doi:10.1016/j.hroo.2026.08.151
Pulmonary Vein Isolation Alone Versus Adjunctive Ablation for Paroxysmal Atrial Fibrillation
Khalil, M. A., Massad, C. M., Tsakiris, E., Herbst, W., Moersdorf, M., Atasi, M. M., Menassa, Y., Darzi, A. E., Khoury, C. E., Bidaoui, G., et al. (2026) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.70519
Chen, M., Soejima, K., Gunawardene, M., Kojodjojo, P., Liu, H., Liu, T., Miyazaki, S., Morishima, I., Sanders, P., Tse, H., et al. (2026) · Journal of Arrhythmia · doi:10.1002/joa3.70492
Metadata
- Authors
- Morillo, C. A., Verma, A., Connolly, S. J., Kuck, K. H., Nair, G. M., Champagne, J., Sterns, L. D., Beresh, H., Healey, J. S., Natale, A., & RAAFT-2 Investigators
- Affiliations
- Population Health Research Institute (CA)
- Southlake Regional Health Center (CA)
- Asklepios Klinik St Georg, Hamburg, Germany
- Ottawa Heart Institute (CA)
- Université Laval (CA)
- Victoria Cardiac Arrhythmia Trials Inc, Victoria, Canada
- McMaster University, Population Health Research Institute, Hamilton Health Sciences, Hamilton, Canada
- St David's Medical Center (US)
- Corresponding author
- Morillo, Carlos A.
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2014-02-19
- Volume
- 311
- Issue
- 7
- Pages
- 692
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2125891322
- Cited by
- 667
- References
- 31
- Citations by year
- 2026: 23 · 2025: 50 · 2024: 58 · 2023: 44 · 2022: 60 · 2021: 68 · 2020: 63 · 2019: 47 · 2018: 45 · 2017: 56 · 2016: 63 · 2015: 48 · 2014: 37
- FWCI
- 46.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Biosense Webster
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- paroxysmal atrial fibrillation, radiofrequency catheter ablation, antiarrhythmic drugs, first-line therapy, atrial tachyarrhythmia recurrence, atrial flutter, atrial tachycardia, quality of life, treatment-naive patients, bleeding risk
- MeSH terms
- Adult, Aged, Anti-Arrhythmia Agents, Atrial Fibrillation, Atrial Flutter, Female, Heart Atria, Humans, Male, Middle Aged, Recurrence, Tachycardia, Treatment Outcome, Catheter Ablation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
